Giusti-Paiva Alexandre, Branco Luiz G S, de Castro Margareth, Antunes-Rodrigues José, Carnio Evelin C
Departamento de Fisiologia, Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, São Paulo, Brasil.
Pflugers Arch. 2003 Nov;447(2):175-80. doi: 10.1007/s00424-003-1164-2. Epub 2003 Oct 3.
We tested the hypothesis that the nitric oxide (NO) pathway in the central nervous system (CNS) plays a role in hypothermia, as well as in the febrile response during experimental septic shock, by regulating vasopressin (AVP) release. Experiments were performed on male Wistar rats treated with NG-nitro-L-arginine methyl ester (L-NAME), a non-selective NO synthase (NOS) inhibitor, injected intracerebroventricularly (250 microg/1 microl) 30 min before lipopolysaccharide (LPS) 1.5 mg/kg i.v. injection. One hour after LPS administration we observed a significant drop in body temperature (hypothermic response), followed by a temperature increase after the second hour (febrile response), which remained until the end of the experiment. Increased plasmatic AVP levels were concomitantly observed during hypothermia, nearly returning to basal levels during the febrile phase. When L-NAME was administered with LPS, plasmatic AVP concentrations remained high throughout the experiment, hypothermia was accentuated and the febrile response was abolished. Additionally, pre-treatment with beta-mercapto-beta,beta-cyclopentamethylenepropionyl1, O-Et-Tyr2, Val4, Arg8-vasopressin, an AVP V1 receptor blocker (10 microg/kg) administered i.v., reduced hypothermia and exacerbated the febrile response to endotoxin. In conclusion, our data indicate that the central NO pathway plays an inhibitory role in AVP release during experimental septic shock, which seems to be critical for the thermoregulation during this pathophysiological state.
我们通过调节血管加压素(AVP)的释放,来验证中枢神经系统(CNS)中的一氧化氮(NO)途径在体温过低以及实验性脓毒性休克期间的发热反应中发挥作用这一假设。实验选用雄性Wistar大鼠,在静脉注射1.5 mg/kg脂多糖(LPS)前30分钟,脑室内注射非选择性NO合酶(NOS)抑制剂NG-硝基-L-精氨酸甲酯(L-NAME,250微克/1微升)。LPS给药1小时后,我们观察到体温显著下降(体温过低反应),随后在第2小时后体温升高(发热反应),该反应一直持续到实验结束。在体温过低期间,血浆AVP水平随之升高,在发热阶段几乎恢复到基础水平。当L-NAME与LPS同时给药时,整个实验过程中血浆AVP浓度均保持在较高水平,体温过低加剧,发热反应消失。此外,静脉注射AVP V1受体阻滞剂β-巯基-β,β-环五亚甲基丙酰1,O-乙基-Tyr2,Val4,Arg8-血管加压素(10微克/千克)进行预处理,可减轻体温过低并加剧对内毒素的发热反应。总之,我们的数据表明,在实验性脓毒性休克期间,中枢NO途径对AVP释放起抑制作用,这似乎对这种病理生理状态下的体温调节至关重要。